Deciphering diabetic nephropathy: Progress using genetic strategies

Current Opinion in Nephrology and Hypertension

Volumn 9, Issue 2, 2000, Pages 99-106

  Adler, Sharon G ^a,d   Pahl, Madeleine ^b   Seldin, Michael F ^c  

^a Research and Education Institute   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; DIABETIC NEPHROPATHY; EDITORIAL; EXTRACELLULAR MATRIX; GENETIC SUSCEPTIBILITY; HUMAN; KIDNEY FAILURE; PATHOGENESIS; PRIORITY JOURNAL;

DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 0034096387     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200003000-00002     Document Type: Editorial

References (141)

1. 1 Anonymous. Excerpts from the United States Renal Data System 1998 Annual Data Report. Am J Kidney Dis 1998; 32(2Suppl 1):S1-S162.
2. 2 Coresh J, Jaar B. Further trends in the etiology of end-stage renal disease in African-Americans. Curr Opin Nephrol Hypertens 1997; 6:243-249.
3. 3 Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 1989; 321:1074-1079.
4. 4 McGill MJ, Donnelly R, Molyneaux L, Yue DK. Ethnic differences in the prevalence of hypertension and proteinuria in NIDDM. Diabetes Res Clin Pract 1996; 33:173-179.
5. 5 Freedman BI, Bowden DW. The role of genetic factors in the development of end-stage renal disease. Curr Opin Nephrol Hypertens 1995; 4:230-234.
6. 6 Chakraborty R, Ferrell RE, Stern MP, Haffner SM, Hazuda HP, Rosenthal M. Relationship of prevalence of non-insulin-dependent diabetes mellitus to Amerindian admixture in the Mexican Americans of San Antonio, Texas. Genet Epidemiol 1986; 3:435-454.
7. 7 Nelson RG, Knowler WC, McCance DR, Sievers ML, Pettitt DJ, Charles MA, et al. Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria. Diabetologia 1993; 36:1087-1093.
8. 8 Haffner SM, Mitchell BD, Pugh JA, Kozlowski MK, Hazuda HP, Patterson JK, Klein R. Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care 1989; 12:530-536.
9. 9 Barzilay J, Warram JH, Bak M, Laffel LM, Canessa M, Krolewski AS. Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Kidney Int 1992; 41:723-730.
10. 10 Fujita J, Tsuda K, Seno M, Obayashi H, Fukui I, Seino Y. Erythrocyte sodium-lithium countertransport activity as a marker of predisposition to hypertension and diabetic nephropathy in NIDDM. Diabetes Care 1994; 17:977-982.
11. 11 Krolewski AA, Canessa M, Warram JH, Laffel LM, Christlieb AR, Knowler WC, Rand LI. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988; 318:140-145.
12. 12 Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin dependent diabetics. Br Med J (Clin Res Ed) 1987; 295:515-517.
13. 13 Sawicki PT, Didjurgeit U, Muhlhauser I, Bender R, Heinemann L, Berger M. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994; 17:126-131.
14. 14 Coonrod BA, Ellis D, Becker DJ, Bunker CH, Kelsey SF, Lloyd CE, et al. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 1993; 16:1376-1383.
15. 15 Grone HJ, Walli AK, Grone EF. Arterial hypertension and hyperlipidemia as determinants of glomerulosclerosis. Clin Invest 1993; 71:834-839.
16. 16 Mulec H, Johnsen SA, Wiklund O, Bjorck S. Cholesterol: a renal risk factor in diabetic nephropathy? Am J Kidney Dis 1993; 22:196-201.
17. 17 Schlondorff D. Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis 1993; 22:72-82.
18. 18 Walli AK, Grone E, Miller B, Grone HJ, Thiery J, Seidel D. Role of lipoproteins in progressive renal disease. Am J Hypertens 1993; 6(11 Part 2):358S-366S.
19. 19 Ismail N, Becker B, Strzelczyk P, Ritz E. Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int 1999; 55:1-28.
20. 20 Doria A, Warram JH, Krolewski AS. Genetic susceptibility to nephropathy in insulin-dependent diabetes: from epidemiology to molecular genetics. Diabetes Metab Rev 1995; 11:287-314.
21. 21 Krolewski AS, Warram JH. Genetic susceptibility to diabetic kidney disease: an update. J Diabetes Compile 1995; 9:277-281.
22. 22 Krolewski AS, Fogarty DG, Warram JH. Hypertension and nephropathy in diabetes mellitus: what is inherited and what is acquired? Diabetes Res Clin Pract 1998; 39(Suppl):S1-S14.
23. 23 Parving HH, Tarnow L, Rossing P. Genetics of diabetic nephropathy. J Am Soc Nephrol 1996; 7:2509-2517.
24. 24 Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984; 74:1143-1155.
25. 25 Adler S. Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy [editorial]. J Am Soc Nephrol 1994; 5:1165-1172.
26. 26 Adler S, Nast C, Artishevsky A. Diabetic nephropathy: pathogenesis and treatment. Annu Rev Med 1993; 44:303-315.
27. 27 Adler S, Feld S. Diabetic nephropathy. Curr Nephrol 1997; 20:153-177.
28. 28 Ibrahim HN, Hostetter TH. Diabetic nephropathy. J Am Soc Nephrol 1997; 8:487-493.
29. 29 Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99:342-348.
30. 30 Daniels BS, Deen WM, Mayer G, Meyer T, Hosteller TH. Glomerular permeability barrier in the rat. Functional assessment by in vitro methods. J Clin Invest 1993; 92:929-936.
31. 31 Ayo SH, Radnik RA, Glass WF, Garoni JA, Rampt ER, Appling DR, Kreisberg JI. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 1991; 260:F185-F191.
32. 32 Cortes P, Zhao X, Riser BL, Narins RG. Role of glomerular mechanical strain in the pathogenesis of diabetic nephropathy. Kidney Int 1997; 51:57-68.
33. 33 Craven PA, Studer RK, Felder J, Phillips S, Derubertis FR. Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells. Diabetes 1997; 46:671-681.
34. 34 Ha H, Yu M-R, Ahn SA, Lee HB. Activation of nuclear factor-kappaB in mesangial cells cultured under high glucose [abstract]. J Am Soc Nephrol 1998; 9:631A.
35. 35 Peten EP, Yang CW, Striker GE, Striker LJ. Gene activation in glomerulosclerosis: a role for growth promoting hormones. Kidney Int Suppl 1994; 45:S48-S50.
36. 36 Kreisberg JI, Ayo SH. The glomerular mesangium in diabetes mellitus. Kidney Int 1993; 43:109-113.
37. 37 Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 1996; 272:728-731.
38. 38 Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 1997; 100:115-126.
39. 39 Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 1997; 272:17810-17814.
40. 40 Yang CW, Hattori M, Vlassara H, He CJ, Carome MA, Yamato E, et al. Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice. J Am Soc Nephrol 1995; 5:1610-1617.
41. 41 Doi T, Vlassara H, Kirstein M, Striker G, Striker LJ. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 1992; 89:2873-2877.
42. 42 Trachtman H, Futterweit S, Franki N, Singhal PC. Effect of vascular endothelial growth factor on nitric oxide production by cultured rat mesangial cells. Biochem Biophys Res Commun 1998; 245:443-446.
43. 43 Andreoli SP. Reactive oxygen molecules, oxidant injury and renal disease. Pediatr Nephrol 1991; 5:733-742.
44. 44 Hoffman BB, Sharma K, Zhu Y, Ziyadeh FN. Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration. Kidney Int 1998; 54:1107-1116.
45. 45 Ziyadeh FN, Han DC, Cohen JA, Guo J, Cohen MP. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system. Kidney Int 1998; 53:631-638.
46. 46 Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999; 274:5830-5834.
47. 47 Oh JH, Ha H, Yu MR, Lee HB. Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis. Kidney Int 1998; 54:1872-1878.
48. 48 Kreisberg JI, Kreisberg SH. High glucose activates protein kinase C and stimulates fibronectin gene expression by enhancing a cAMP response element. Kidney Int Suppl 1995; 51:S3-S11.
49. 49 Nahman NSJ, Leonhart KL, Cosio FG, Hebert CL. Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int 1992; 41:396-402.
50. 50 Pugliese G, Pricci F, Mene P, Romeo G, Nofroni I, Giannini S, et al. High glucose level unmasks a genetic predisposition to enhanced extracellular matrix production in mesangial cells from the Milan normotensive strain. J Am Soc Nephrol 1997; 8:406-414.
51. 51 Iehara N, Takeoka H, Yamada Y, Kita T, Doi T. Advanced glycation end products modulate transcriptional regulation in mesangial cells. Kidney Int 1996; 50:1166-1172.
52. 52 Hasslacher C, Wahl P. Influence of diabetes control on synthesis of protein and basement membrane collagen in isolated glomeruli of diabetic rats. Res Exp Med (Berl) 1980; 176:247-253.
53. 53 Kitamura M, Kitamura A, Mitarai T, Maruyama N, Nagasawa R, Kawamura T. et al. Gene expression of metalloproteinase and its inhibitor in mesangial cells exposed to high glucose. Biochem Biophys Res Commun 1992; 185:1048-1054.
54. 54 Nakamura T, Fukui M, Ebihara I, Osada S, Tomino Y, Koide H. Abnormal gene expression of matrix metalloproteinases and their inhibitor in glomeruli from diabetic rats. Ren Physiol Biochem 1994; 17:316-325.
55. 55 Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, Cortes P. Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 1995; 96:1802-1814.
56. 56 Roy S, Sala R, Cagliero E, Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 1990; 87:404-408.
57. 57 Poulsom R, Kurkinen M, Prockop DJ, Boot-Handford RP. Increased steady-state levels of laminin B1 mRNA in kidneys of long-term streptozotocin-diabetic rats. No effect of an aldose reductase inhibitor. J Biol Chem 1988; 263:10072-10076.
58. 58 Ledbetter S, Copeland EJ, Noonan D, Vogeli G, Hassell JR. Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 1990; 39:196-203.
59. 59 Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H. ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 1992; 41:1520-1527.
60. 60 Nakamura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y, Koide H. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 1993; 42:450-456.
61. 61 Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993; 90:1814-1818.
62. 62 Pankewycz OG, Guan JX, Bolton WK, Gomez A, Benedict JF. Renal TGF-beta regulation in spontaneously diabetic NOD mice with correlations in mesangial cells. Kidney Int 1994; 46:748-758.
63. 63 Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, et al. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 1995; 47:935-944.
64. 64 Throckmorton DC, Brogden AP, Min B, Rasmussen H, Kashgarian M. PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int 1995; 48:111-117.
65. 65 Ihm CG, Lee GS, Nast CC, Artishevsky A, Guillermo R, Levin PS, et al. Early increased renal procollagen alpha 1(IV) mRNA levels in streptozotocin induced diabetes. Kidney Int 1992; 41:768-777.
66. 66 Riser BL, Cortes P, Yee J, Sharba AK, Asano K, Rodriguez-Barbero A, Narins RG. Mechanical strain- and high glucose-induced alterations in mesangial cell collagen metabolism: role of TGF-beta. J Am Soc Nephrol 1998; 9:827-836.
67. 67 Vora JP, Oyama TT, Thompson MM, Anderson S. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes. Diabetes 1997; 46:107-112.
68. 68 Anderson S, Vora JP. Current concepts of renal hemodynamics in diabetes. J Diabetes Complic 1995; 9:304-307.
69. 69 Ha H, Roh DD, Kirschenbaum MA, Kamanna VS. Atherogenic lipoproteins enhance mesangial cell expression of platelet-derived growth factor: role of protein tyrosine kinase and cyclic AMP-dependent protein kinase A. J Lab Clin Med 1998; 131:456-465.
70. 70 Cohen MP, Khalifa A. Renal glomerular collagen synthesis in streptozotocin diabetes. Reversal of increased basement membrane synthesis with insulin therapy. Biochim Biophys Acta 1977; 500:395-404.
71. 71 Falk RJ, Scheinman JI, Mauer SM, Michael AF. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 1983; 32(Suppl 2):34-39.
72. 72 Yagame M, Kim Y, Zhu D, Suzuki D, Eguchi K, Nomoto Y, et al. Differential distribution of type IV collagen chains in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995; 70:42-48.
73. 73 Karttunen T, Risteli J, Autio-Harmainen H, Risteli L. Effect of age and diabetes on type IV collagen and laminin in human kidney cortex. Kidney Int 1986; 30:586-591.
74. 74 Nerlich A, Schleicher E. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 1991; 139:889-899.
75. 75 Adler SG, Feld S, Striker L, Striker G, LaPage J, Cha DR, et al. In IDDM, elevated glomerular procollagen alpha2(IV) mRNA levels reflect the proteinuric state and may predict progression from normoalbuminuria [abstract]. J Am Soc Nephrol 1996; 9:112A.
76. 76 Adler SG, Feld SM, Striker L, Striker G, LaPage J, Espositio C, et al. Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disorders. Kidney Int 2000 (In press).
77. 77 Zhu D, Kim Y, Steffes MW, Groppoli TJ, Butkowski RJ, Mauer SM. Glomerular distribution of type IV collagen in diabetes by high resolution quantitative immunochemistry. Kidney Int 1994; 45:425-433.
78. 78 Del Prete D, Anglani F, Forino M, Ceol M, Fioretto P, Nosadini R, et al. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. Diabetologia 1997; 40:1449-1454.
79. 79 Iwano M, Kubo A, Nishino T, Sato H, Nishioka H, Akai Y, et al. Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus. Kidney Int 1996; 49:1120-1126.
80. 80 Sugimoto H, Shikata K, Hirata K, Akiyama K, Matsuda M, Kushiro M, et al. Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes 1997; 46:2075-2081.
81. 81 Jin DK, Fish AJ, Wayner EA, Mauer M, Setty S, Tsilibary E, Kim Y. Distribution of integrin subunits in human diabetic kidneys. J Am Soc Nephrol 1996; 7:2636-2645.
82. 82 Zhou X, Li C, Dlugosz J, Kapor-Drezgic J, Munk S, Whiteside C. Mesangial cell actin disassembly in high glucose mediated by protein kinase C and the polyol pathway. Kidney Int 1997; 51:1797-1808.
83. 83 Zhou X, Hurst RD, Templeton D, Whiteside CI. High glucose alters actin assembly in glomerular mesangial and epithelial cells. Lab Invest 1995; 73:372-383.
84. 84 Anonymous. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997; 46:1829-1839.
85. 85 Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence tor genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320:1161-1165.
86. 86 Freedman BI, Spray BJ, Tuttle AB, Buckalew VMJ. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 1993; 21:387-393.
87. 87 Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1995; 25:710-713.
88. 88 Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH. Is diabetic nephropathy an inherited complication? Kidney Int 1992; 41:719-722.
89. 89 McCance DR, Hanson RL, Pettitt DJ, Jacobsson LT, Bennett PH, Bishop DT, Knowler WC. Diabetic nephropathy: a risk factor for diabetes mellitus in offspring. Diabetologia 1995; 38:221-226.
90. 90 Mangili R, Bending JJ, Scott G, Li LK, Gupta A, Viberti G. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1988; 318:146-150.
91. 91 Elving LD, Wetzels JF, De Nobel E, Berden JH. Erythrocyte sodium-lithium countertransport is not different in type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia 1991; 34:126-128.
92. 92 Hardman TC, Dubrey SW, Leslie DG, Hafiz M, Noble MI, Lant AF. Erythrocyte sodium-lithium countertransport and blood pressure in identical twin pairs discordant for insulin dependent diabetes. Br Med J 1992; 305:215-219.
93. 93 Pinkney JH, Foyle WJ, Denver AE, Mohamed-Ali V, McKinlay S, Yudkin JS. The relationship of urinary albumin excretion rate to ambulatory blood pressure and erythrocyte sodium-lithium countertransport in NIDDM. Diabetologia 1995; 38:356-362.
94. 94 Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990; 33:438-443.
95. 95 Quinn M, Angelico MC, Warram JH, Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996; 39:940-945.
96. 96 Faronato PP, Maioli M, Tonolo G, Brocco E, Noventa F, Piarulli F, et al. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group. Diabetologia 1997; 40:816-823.
97. 97 Canani LH, Gerchman F, Gross JL. Increased familial history of arterial hypertension, coronary heart disease, and renal disease in Brazilian type 2 diabetic patients with diabetic nephropathy. Diabetes Care 1998; 21:1545-1550.
98. 98 Brown DM, Provoost AP, Daly MJ, Lander ES, Jacob HJ. Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nature Genet 1996; 12:44-51.
99. 99 Yu H, Sale M, Rich SS, Spray BJ, Roh BH, Bowden DW, Freedman BI. Evaluation of markers on human chromosome 10, including the homologue of the rodent Rf-1 gene, for linkage to ESRD in black patients. Am J Kidney Dis 1999; 33:294-300.
100. 100 Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 1998; 47:821-830.
101. 101 Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 1998; 47:1164-1169.
102. 102 Krolewski AS. Genetics of diabetic nephropathy: evidence for major and minor gene effects. Kidney Int 1999; 55:1582-1596.
103. 103 Chakraborty R, Weiss KM. Admixture as a tool for finding linked genes and detecting that difference from allelic association beteween loci. Proc Natl Acad Sci USA 1988; 85:9119-9123.
104. 104 Stephens JC, Briscoe D, O'Brien SJ. Mapping by admixture linkage disequilibrium in human populations: limits and guidelines. Am J Hum Genet 1994; 55:809-824.
105. 105 McKeigue PM. Mapping genes that underly ethnic differences in disease risk: methods for detecting linkage in admixed populations, by conditioining on parental admixture. Am J Hum Genet 1998; 63:241-251.
106. 106 Editor. Freely associating. Nature Genet 1999; 22:1-2.
107. 107 Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996; 59:983-989.
108. 108 McGinnis RE, Ewens WJ, Spielman RS. The TDT reveals linkage and linkage disequilibrium in a rare disease. Genet Epidemiol 1995; 12:637-640.
109. 109 Ewens WJ, Spielman RS. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet 1995; 57:455-464.
110. 110 Doi Y, Yoshizumi H, Yoshinari M, Iino K, Yamamoto M, Ichikawa K, et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996; 39:97-102.
111. 111 Dudley CR, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ. U.K. Prospective Diabetes Study. XV: relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995; 48:1907-1911.
112. 112 Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, Fushimi T, et al. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995; 70:455-459.
113. 113 Ohno T, Kawazu S, Tomono S. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 1996; 45:218-222.
114. 114 Fujisawa T, Ikegami H, Shen GQ, Yamato E, Takekawa K, Nakagawa Y, et al. Angiotensin l-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995; 18:983-985.
115. 115 Schmidt S, Schone N, Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int 1995; 47:1176-1181.
116. 116 Panagiotopoulos S, Smith TJ, Aldred GP, Baker EJ, Jacklin CJ, Jerums G. Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate. J Diabetes Complic 1995; 9:272-276.
117. 117 Freire MB, Ji L, Onuma T, Orban T, Warram JH, Krolewski AS. Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. Hypertension 1998; 31:896-899.
118. 118 Kimura H, Suzuki Y, Gejyo F, Karasawa R, Miyazaki R, Suzuki S, Arakawa M. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM. Am J Kidney Dis 1998; 31:666-673.
119. 119 Nishigori H, Yamada S, Kohama T, Tomura H, Sho K, Horikawa Y, et al. Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes 1998; 47:1354-1355.
120. 120 Freedman BI, Yu H, Spray BJ, Rich SS, Rothschild CB, Bowden DW. Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. Kidney Int 1997; 51:819-825.
121. 121 Yu H, Bowden DW, Spray BJ, Rich SS, Freedman BI. Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease. Hypertension 1998; 31:906-911.
122. 122 Maeda S, Haneda M, Hayashi K, Koya D, Kikkawa R. (A-C)n dinucleotide repeat polymorphism at 5′ end of matrix metalloproteinase 9 gene is associated with nephropathy in Japanese subjects with type 2 diabetes [abstract]. J Am Soc Nephrol 1998; 9:118A.
123. 123 Patel A, Hibberd ML, Millward BA, Emaine AG. Chromosome 7q35 and susceptibility to diabetic microvascular complications. J Diabetes Complic 1996; 10:62-67.
124. 124 Chen JW, Hansen PM, Tarnow L, Hellgren A, Deckert T, Pociot F. Genetic variation of a collagen IV alpha 1-chain gene polymorphism in Danish insulin-dependent diabetes mellitus (IDDM) patients: lack of association to nephropathy and proliferative retinopathy. Diabetes Med 1997; 14:143-147.
125. 125 Loughrey BV, Maxwell AP, Fogarty DG, Middleton D, Harron JC, Patterson CC, et al. An interluekin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy. Cytokine 1998; 10:984-988.
126. 126 Tarnow L, Pociot F, Hansen PM, Rossing P, Nielsen FS, Hansen BV, Parving HH. Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDM. Diabetes 1997; 46:1075-1076.
127. 127 Schmidt S, Bluthner M, Giessel R, Strojek K, Bergis KH, Grzeszczak W, Ritz E. A polymorphism in the gene for the atrial natriuretic peptide and diabetic nephropathy. Diabetic Nephropathy Study Group. Nephrol Dial Transplant 1998; 13:1807-1810.
128. 128 Shah VO, Scavini M, Nikolic J, Sun Y, Vai S, Griffith JK, et al. Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy. J Clin Endocrinol Metab 1998; 83:2886-2891.
129. 129 Heesom AE, Hibberd ML, Millward A, Demaine AG. Polymorphism in the 5′-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes. Diabetes 1997; 46:287-291.
130. 130 Fogarty DG, Zychma MJ, Scott LJ, Warram JH, Krolewski AS. The c825T polymorphism in the human G-protein beta3 subunit gene is not associated with diabetic nephropathy in Type 1 diabetes mellitus. Diabetologia 1998; 41:1304-1308.
131. 131 Pociot F, Hansen PM, Karlsen AE, Langdahl BL, Johannesen J, Nerup J. TGF-beta1 gene mutations in insulin-dependent diabetes mellitus and diabetic nephropathy. J Am Soc Nephrol 1998; 9:2302-2307.
132. 132 Rogus JJ, Moczulski D, Freire MB, Yang Y, Warram JH, Krolewski AS. Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. Hypertension 1998; 31:627-631.
133. 133 Schmidt S, Giessel R, Bergis KH, Strojek K, Grzeszczak W, Ganten D, Ritz E. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant 1996; 11:1755-1761.
134. 134 Doria A, Onuma T, Warram JH, Krolewski AS. Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM. Diabetologia 1997; 40:1293-1299.
135. 135 Onuma T, Laffel LM, Angelico MC, Krolewski AS. Apolipoprotein E genotypes and risk of diabetic nephropathy. J Am Soc Nephrol 1996; 7:1075-1078.
136. 136 Onuma T, Laffel LM, Angelico MC, Krolewski AS. Apolipoprotein E genotypes and risk of diabetic nephropathy. J Am Soc Nephrol 1996; 7:1075-1078.
137. 137 Araki S, Moczulski DK, Zanchi A, Warram JH, Krolewski AS. APO epsilon2 is causally related to the development of diabetic nephropathy [abstract]. J Am Soc Nephrol 1998; 9:113A.
138. 138 Smyth JS, Savage DA, Maxwell AP. Lack of association between endothelin-1 and endothelinA receptor polymorphisms and diabetic nephropathy in IDDM [abstract]. J Am Soc Nephrol 1998; 9:123A.
139. 139 Deinum J, Tarnow L, Van Gool JM, De Bruin RA, Derkx FH, Schalekamp MA, Parving HH. Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy. Nephrol Dial Transplant 1999; 14:1904-1911.
140. 140 Nannipieri M, Penno G, Pucci L, Colhoun H, Motti C, Bertacca A, et al. Pronatriodilatin gene polymorphisms, microvascular permeability, and diabetic nephropathy in type 1 diabetes mellitus. J Am Soc Nephrol 1999; 10:1530-1541.
141. 141 Tarnow L, Urhammer SA, Mottlau B, Hansen BV, Pedersen O, Parving HH. The Trp64Arg amino acid polymorphism of the beta3-adrenergic receptor gene does not contribute to the genetic susceptibility of diabetic microvascular complications in Caucasian type 1 diabetic patients. Nephrol Dial Transplant 1999; 14:895-897.